The core purpose of the East Midlands Cancer Clinical Network is to improve health outcomes for patients across the region.  The Network does this by:

  • Sharing best practice - including individual pathway reviews which look at eliminating any unnecessary waste in the system.
  • Providing expert clinical advice to facilitate change in the system through our Expert Clinical Advisory Groups.
  • Addressing any unwarranted variation across the region - improving patient experience and ensuring access to services is consistent across the region.

The Network is allied to both the Clinical Senate and the Diagnostics Work Programme.

Further information can be found within the Work Programme pages of our website.

Our clinical director is Dr Stephen Ryder, who also chairs the Cancer Steering Group, which meets quarterly.  The steering group has day-to-day responsibility for the strategic and operational development and delivery of the East Midlands Cancer Clinical Network.  It has delegated authority from the East Midlands Oversight Group for agreed decision making responsibilities, including the development and delivery of work plans.  Membership of the group includes representatives from public health, screening programmes, cancer strategy boards, lead cancer nurses from provider trusts, patient or patient organisation, and local authorities. The group's core activities include leading, developing, and overseeing the East Midlands Cancer Clinical Network in line with national policy and local priorities to ensure the quality of planned improvements and the achievement of outcomes.